Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma

NCT00907348 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

49

Enrollment

OTHER

Sponsor class

Conditions

Non Hodgkin Lymphoma
Follicular Lymphoma

Interventions

DRUG: LR-CHOP21

Sponsor

Fondazione Italiana Linfomi - ETS

Collaborators

[object Object]